The 340B drug pricing program has evolved from a “buy low, sell low” program to help safety-net hospitals serve low-income [...] …
Category: Federal
Health system greed has “made a mockery” of the 340B drug pricing program and leads to practices that widen health [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Medicare Part B plans to continue paying the statutory default rate—generally average sales price plus 6%—for 340B acquired drugs and [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The U.S. Chamber of Commerce asked a federal district court in Ohio last week to stop Medicare from implementing the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Generic and over-the-counter drug manufacturer VistaPharm said in a public notice this week that it has identified 340B covered entities [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A $9 billion Medicare proposal to repay 340B hospitals for unlawful Part B drug payment cuts includes a spreadsheet showing [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
On a sunny, humid, 92-degree afternoon in Washington, D.C., over 50 safety-net health care providers marched to the U.S. Capitol [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Provider groups widely celebrated the Medicare proposal to provide a $9 billion lump sum payment to reimburse 340B hospitals for [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Low-cost generic drugs should get an exemption from the 340B drug pricing program to help reduce drug shortages, the U.S. [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A leading not-for-profit HIV and AIDS treatment organization amplified its 340B advocacy recently with an op-ed in a Washington, D.C., [...] …